COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS

Bibliographic Details
Main Authors:	Matthews, L, Palace, J, Deoni, S, Leite, M, Johansen-Berg, H, Kolind, S
Format:	Conference item
Published:	2010

Similar Items

Myelin water imaging reflects clinical variability in multiple sclerosis.
by: Kolind, S, et al.
Published: (2012)

Myelin water imaging reflects clinical variability in multiple sclerosis
by: Kolind, S, et al.
Published: (2012)

AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
by: Arun, T, et al.
Published: (2012)

Distinction of aquaporin-4 antibody positive neuromyelitis optica from multiple sclerosis using diffusion tensor and myelin water imaging
by: Matthews, L, et al.
Published: (2011)

Myelin imaging in amyotrophic and primary lateral sclerosis.
by: Kolind, S, et al.
Published: (2013)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
by: Lucy Matthews, et al.
Published: (2015-01-01)

Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker
by: Shannon Kolind, et al.
Published: (2015-01-01)

MS patients with chronic pain have more myelin water and less heterogeneous T1 values in normal-appearing white matter than matched MS patients without pain
by: Kolind, S, et al.
Published: (2009)

Multi-component relaxation reveals distinct patterns of white matter involvement in primary progressive multiple sclerosis and primary lateral sclerosis
by: Kolind, S, et al.
Published: (2012)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
by: Matthews, L, et al.
Published: (2012)

Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis
by: Hagen H. Kitzler, et al.
Published: (2022-01-01)

THE THALAMUS AND NEUROPATHIC PAIN IN MULTIPLE SCLEROSIS
by: Seixas, D, et al.
Published: (2009)

Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorder
by: Anna J.E. Combes, et al.
Published: (2017-01-01)

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
by: Cader, S, et al.
Published: (2007)

MOTOR SKILL LEARNING IN MULTIPLE SCLEROSIS
by: Tomassini, V, et al.
Published: (2009)

Primary progressive multiple sclerosis: Brain MRI findings
by: Kremenchutzky, M, et al.
Published: (1999)

Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis
by: Massella Alessandro, et al.
Published: (2012-01-01)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
by: Matthews, L, et al.
Published: (2012)

Functional correlates of motor learning in multiple sclerosis
by: Tomassini, V, et al.
Published: (2009)

ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
by: Arun, T, et al.
Published: (2013)

EVIDENCE OF SUBCORTICAL ATROPHY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
by: Arun, T, et al.
Published: (2009)

Diagnostic brain MRI findings in primary progressive multiple sclerosis.
by: Kremenchutzky, M, et al.
Published: (2000)

Antibodies to myelin lipids in multiple sclerosis
by: M. V. Ivanova, et al.
Published: (2017-02-01)

Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging.
by: Lee, M, et al.
Published: (1998)

Relating brain damage to brain plasticity in patients with multiple sclerosis.
by: Tomassini, V, et al.
Published: (2012)

Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells
by: Panagiotis Douvaras, et al.
Published: (2014-08-01)

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
by: Arun, T, et al.
Published: (2013)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
by: Arun, T, et al.
Published: (2013)

Modifying disability in progressive multiple sclerosis.
by: Palace, J, et al.
Published: (2014)

Modifying disability in progressive multiple sclerosis
by: Palace, J, et al.
Published: (2014)

Preservation of motor skill learning in patients with multiple sclerosis
by: Tomassini, V, et al.
Published: (2011)

Preservation of motor skill learning in patients with multiple sclerosis.
by: Tomassini, V, et al.
Published: (2011)

Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a
by: Shannon Kolind, et al.
Published: (2022-01-01)

Feasibility of Imaging Myelin Lesions in Multiple Sclerosis
by: Maria I. Zavodszky, et al.
Published: (2011-01-01)

Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination
by: Edward L. Hogan, et al.
Published: (2013-08-01)

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.
by: Chen, J, et al.
Published: (2004)

Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis
by: Kawita M. S. Kanhai, et al.
Published: (2022-03-01)

The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.
by: Gelineau-Morel, R, et al.
Published: (2012)

COMPARISON OF HISTOLOGICAL AND DIFFUSION-WEIGHTED MRI TECHNIQUES IN THE ANALYSIS OF POST MORTEM MULTIPLE SCLEROSIS BRAINS
by: Kolasinski, J, et al.
Published: (2012)

Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis
by: Wen Wei, et al.
Published: (2020-12-01)